Banks - Regional
Compare Stocks
5 / 10Stock Comparison
CARE vs NKSH vs NBTB vs UVSP vs FIS
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Information Technology Services
CARE vs NKSH vs NBTB vs UVSP vs FIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Information Technology Services |
| Market Cap | $580M | $240M | $2.35B | $1.10B | $24.47B |
| Revenue (TTM) | $255M | $85M | $867M | $518M | $10.89B |
| Net Income (TTM) | $31M | $16M | $169M | $91M | $382M |
| Gross Margin | 61.7% | 65.1% | 72.1% | 61.0% | 38.1% |
| Operating Margin | 15.7% | 22.5% | 25.3% | 21.9% | 17.5% |
| Forward P/E | 4.8x | 11.7x | 10.8x | 11.1x | 7.5x |
| Total Debt | $179M | $2M | $327M | $352M | $4.01B |
| Cash & Equiv. | $105M | $8M | $185M | $554M | $599M |
CARE vs NKSH vs NBTB vs UVSP vs FIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| National Bankshares… (NKSH) | 100 | 122.4 | +22.4% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Univest Financial C… (UVSP) | 100 | 234.7 | +134.7% |
| Fidelity National I… (FIS) | 100 | 34.0 | -66.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NKSH vs NBTB vs UVSP vs FIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE has the current edge in this matchup, primarily because of its strength in stability and momentum.
- Beta 0.56 vs UVSP's 1.01
- +69.0% vs FIS's -35.3%
NKSH is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.76, yield 4.0%
- Rev growth 7.9%, EPS growth 100.8%
- Lower volatility, beta 0.76, Low D/E 1.1%, current ratio 1203.84x
- Beta 0.76, yield 4.0%, current ratio 1203.84x
NBTB is the #2 pick in this set and the best alternative if bank quality is your priority.
- NIM 3.1% vs NKSH's 2.5%
- 10.4% NII/revenue growth vs UVSP's 3.6%
- 19.5% margin vs FIS's 3.5%
UVSP is the clearest fit if your priority is long-term compounding.
- 140.1% 10Y total return vs CARE's 112.9%
FIS ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.31 vs NBTB's 1.53
- Lower P/E (7.5x vs 10.8x), PEG 0.31 vs 1.53
- 1.1% ROA vs CARE's 0.7%, ROIC 6.0% vs 5.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs UVSP's 3.6% | |
| Value | Lower P/E (7.5x vs 10.8x), PEG 0.31 vs 1.53 | |
| Quality / Margins | 19.5% margin vs FIS's 3.5% | |
| Stability / Safety | Beta 0.56 vs UVSP's 1.01 | |
| Dividends | 4.0% yield, 1-year raise streak, vs NBTB's 3.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +69.0% vs FIS's -35.3% | |
| Efficiency (ROA) | 1.1% ROA vs CARE's 0.7%, ROIC 6.0% vs 5.7% |
CARE vs NKSH vs NBTB vs UVSP vs FIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CARE vs NKSH vs NBTB vs UVSP vs FIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 1 of 6 categories
UVSP leads 1 • NKSH leads 1 • CARE leads 0 • FIS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FIS is the larger business by revenue, generating $10.9B annually — 127.7x NKSH's $85M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to FIS's 3.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $255M | $85M | $867M | $518M | $10.9B |
| EBITDAEarnings before interest/tax | $46M | $20M | $241M | $119M | $3.8B |
| Net IncomeAfter-tax profit | $31M | $16M | $169M | $91M | $382M |
| Free Cash FlowCash after capex | $30M | $17M | $225M | $92M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +61.7% | +65.1% | +72.1% | +61.0% | +38.1% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +22.5% | +25.3% | +21.9% | +17.5% |
| Net MarginNet income ÷ Revenue | +12.3% | +18.6% | +19.5% | +17.5% | +3.5% |
| FCF MarginFCF ÷ Revenue | +12.5% | +17.8% | +25.2% | +18.7% | +26.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +91.7% | +39.5% | +23.1% | +92.3% |
Valuation Metrics
UVSP leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 12.2x trailing earnings, UVSP trades at a 81% valuation discount to FIS's 63.0x P/E. Adjusting for growth (PEG ratio), UVSP offers better value at 0.84x vs NKSH's 145.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $580M | $240M | $2.4B | $1.1B | $24.5B |
| Enterprise ValueMkt cap + debt − cash | $654M | $234M | $2.5B | $897M | $27.9B |
| Trailing P/EPrice ÷ TTM EPS | 18.71x | 15.14x | 13.53x | 12.21x | 63.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.77x | 11.71x | 10.80x | 11.10x | 7.54x |
| PEG RatioP/E ÷ EPS growth rate | — | 145.48x | 1.92x | 0.84x | 2.58x |
| EV / EBITDAEnterprise value multiple | 16.34x | 12.20x | 10.35x | 7.49x | 7.66x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.81x | 2.71x | 2.12x | 2.29x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.30x | 1.21x | 1.18x | 1.76x |
| Price / FCFMarket cap ÷ FCF | 18.25x | 15.85x | 10.75x | 11.34x | 9.97x |
Profitability & Efficiency
NKSH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
UVSP delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $3 for FIS. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs FIS's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +9.0% | +9.5% | +9.8% | +2.7% |
| ROA (TTM)Return on assets | +0.7% | +0.9% | +1.1% | +1.1% | +1.1% |
| ROICReturn on invested capital | +5.7% | +8.4% | +7.9% | +6.5% | +6.0% |
| ROCEReturn on capital employed | +1.5% | +1.9% | +2.4% | +8.8% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 8 | 7 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.43x | 0.01x | 0.17x | 0.37x | 0.29x |
| Net DebtTotal debt minus cash | $73M | -$6M | $142M | -$202M | $3.4B |
| Cash & Equiv.Liquid assets | $105M | $8M | $185M | $554M | $599M |
| Total DebtShort + long-term debt | $179M | $2M | $327M | $352M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.64x | 1.05x | 0.60x | 4.64x |
Total Returns (Dividends Reinvested)
Evenly matched — CARE and UVSP each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $3,685 for FIS. Over the past 12 months, CARE leads with a +69.0% total return vs FIS's -35.3%. The 3-year compound annual growth rate (CAGR) favors UVSP at 33.4% vs FIS's -2.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.8% | +14.2% | +9.3% | +20.9% | -27.3% |
| 1-Year ReturnPast 12 months | +69.0% | +49.7% | +9.0% | +32.0% | -35.3% |
| 3-Year ReturnCumulative with dividends | +94.7% | +55.1% | +54.1% | +137.1% | -6.6% |
| 5-Year ReturnCumulative with dividends | +87.2% | +31.9% | +29.9% | +46.4% | -63.2% |
| 10-Year ReturnCumulative with dividends | +112.9% | +51.3% | +102.2% | +140.1% | -13.2% |
| CAGR (3Y)Annualised 3-year return | +24.9% | +15.7% | +15.5% | +33.4% | -2.2% |
Risk & Volatility
Evenly matched — CARE and UVSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than UVSP's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UVSP currently trades 98.8% from its 52-week high vs FIS's 57.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 0.76x | 0.89x | 1.01x | 0.76x |
| 52-Week HighHighest price in past year | $26.58 | $40.00 | $46.92 | $39.06 | $82.74 |
| 52-Week LowLowest price in past year | $15.37 | $24.74 | $39.20 | $27.91 | $43.30 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +94.3% | +96.1% | +98.8% | +57.1% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 51.1 | 57.3 | 68.1 | 43.3 |
| Avg Volume (50D)Average daily shares traded | 276K | 50K | 236K | 180K | 5.5M |
Analyst Outlook
Evenly matched — NKSH and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CARE as "Buy", NKSH as "Buy", NBTB as "Hold", UVSP as "Hold", FIS as "Buy". Consensus price targets imply 42.6% upside for FIS (target: $67) vs -11.9% for UVSP (target: $34). For income investors, NKSH offers the higher dividend yield at 4.01% vs UVSP's 2.28%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $27.00 | — | $46.00 | $34.00 | $67.38 |
| # AnalystsCovering analysts | 4 | 4 | 10 | 6 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | +4.0% | +3.2% | +2.3% | +3.5% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 12 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | $1.51 | $1.43 | $0.88 | $1.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | 0.0% | +0.4% | +3.2% | 0.0% |
NBTB leads in 1 of 6 categories (Income & Cash Flow). UVSP leads in 1 (Valuation Metrics). 3 tied.
CARE vs NKSH vs NBTB vs UVSP vs FIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CARE or NKSH or NBTB or UVSP or FIS a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus 3. 6% for Univest Financial Corporation (UVSP). Univest Financial Corporation (UVSP) offers the better valuation at 12. 2x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NKSH or NBTB or UVSP or FIS?
On trailing P/E, Univest Financial Corporation (UVSP) is the cheapest at 12.
2x versus Fidelity National Information Services, Inc. at 63. 0x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fidelity National Information Services, Inc. wins at 0. 31x versus National Bankshares, Inc. 's 145. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CARE or NKSH or NBTB or UVSP or FIS?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -63. 2% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: UVSP returned +140. 1% versus FIS's -13. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NKSH or NBTB or UVSP or FIS?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus Univest Financial Corporation's 1. 01β — meaning UVSP is approximately 80% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NKSH or NBTB or UVSP or FIS?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus 3. 6% for Univest Financial Corporation (UVSP). On earnings-per-share growth, the picture is similar: National Bankshares, Inc. grew EPS 100. 8% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NKSH or NBTB or UVSP or FIS?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 3. 6% for Fidelity National Information Services, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NKSH or NBTB or UVSP or FIS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fidelity National Information Services, Inc. (FIS) is the more undervalued stock at a PEG of 0. 31x versus National Bankshares, Inc. 's 145. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for National Bankshares, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 42. 6% to $67. 38.
08Which pays a better dividend — CARE or NKSH or NBTB or UVSP or FIS?
In this comparison, NKSH (4.
0% yield), FIS (3. 5% yield), NBTB (3. 2% yield), UVSP (2. 3% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NKSH or NBTB or UVSP or FIS better for a retirement portfolio?
For long-horizon retirement investors, National Bankshares, Inc.
(NKSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), 4. 0% yield). Both have compounded well over 10 years (NKSH: +51. 3%, CARE: +112. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NKSH and NBTB and UVSP and FIS?
These companies operate in different sectors (CARE (Financial Services) and NKSH (Financial Services) and NBTB (Financial Services) and UVSP (Financial Services) and FIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CARE is a small-cap quality compounder stock; NKSH is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; UVSP is a small-cap deep-value stock; FIS is a mid-cap income-oriented stock. NKSH, NBTB, UVSP, FIS pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.